Bristol-Myers Squibb Company
Combination of TIM-4 antagonist and PD-1 antagonist and methods of use

Abstract:

Provided are methods and compositions for treating cancer using an effective amount of a PD-1 antagonist (e.g., an antibody) in combination with a TIM-4 antagonist (e.g., an antibody).